CD8+ T-cell Differentiation And Treatment Response In AML; ATM Germline Pathogenic Variants Affect Cancer Outcomes In Ataxia-telangiectasia; Efficacy Of A Selective Menin-KMT2A Inhibitor In KMT2A- And NPM1-altered Leukemias Blood podcast

Conteúdo fornecido por American Society of Hematology. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por American Society of Hematology ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

Blood Podcast »
CD8+ T-cell differentiation and treatment response in AML; ATM germline pathogenic variants affect cancer outcomes in ataxia-telangiectasia; efficacy of a selective menin-KMT2A inhibitor in KMT2A- and NPM1-altered leukemias

5d ago 22:42

MP3•Home de episódios

In this week's episode we’ll discuss how CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia; learn more about the effect of ATM germline pathogenic variants on the outcomes in children with ataxia-telangiectasia and hematological malignancies; and discuss the preclinical efficacy of a potent, selective menin-KMT2A inhibitor JNJ-75276617 in KMT2A- and NPM1-altered leukemias.

Featured Articles:

275 episódios

#Science #Hematology #Oncology #Medical #Medical Research #Biology Education #Science Education #Podcasting Education #Fitness #Medicine #American Society Of Hematology